Literature DB >> 25557165

Fatigue in psoriasis: a phenomenon to be explored.

I M Skoie1, T Ternowitz1, G Jonsson2, K Norheim3, R Omdal3,4.   

Abstract

Fatigue is a prevalent and substantial phenomenon in many patients with chronic inflammatory diseases, often rated by patients as the most troublesome symptom and aspect of their disease. It frequently interferes with physical and social functions and may lead to social withdrawal, long-standing sick leave and disability. Although psychological and somatic factors such as depression, sleep disorders, pain and anaemia influence fatigue, the underlying pathophysiological mechanisms by which fatigue is generated and regulated are largely unknown. Increasing evidence points towards a genetic and molecular basis for fatigue as part of the innate immune system and cellular stress responses. Few studies have focused on fatigue in dermatological diseases. Most of these studies describe fatigue as a phenomenon related to psoriatic arthritis and describe the beneficial effects of biological agents on fatigue observed in clinical studies. It is therefore possible that this problem has been underestimated and deserves more attention in the dermatological community. In this review, we provide a definition and explanation for chronic fatigue, describe some commonly used instruments for measuring fatigue, and present hypothetical biological mechanisms with an emphasis on activation of the innate immune system and oxidative stress. An overview of relevant clinical studies covering the theme 'psoriasis and fatigue' is given.
© 2014 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25557165     DOI: 10.1111/bjd.13647

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

Review 1.  Comorbidity in Adult Psoriasis: Considerations for the Clinician.

Authors:  Christine Daugaard; Lars Iversen; Kasper Fjellhaugen Hjuler
Journal:  Psoriasis (Auckl)       Date:  2022-06-10

2.  Evaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis.

Authors:  Claudio Carneiro; Mario Chaves; Gustavo Verardino; Ana Paula Frade; Pedro Guimaraes Coscarelli; Washington Alves Bianchi; Marcia Ramos-E-Silva; Sueli Carneiro
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-05-08

3.  Increased risk of chronic fatigue syndrome following psoriasis: a nationwide population-based cohort study.

Authors:  Shin-Yi Tsai; Hsuan-Ju Chen; Chi Chen; Chon-Fu Lio; Chien-Feng Kuo; Kam-Hang Leong; Yu-Ting Tina Wang; Tse-Yen Yang; Ching-Hui You; Wei-Sheng Wang
Journal:  J Transl Med       Date:  2019-05-14       Impact factor: 5.531

4.  Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study.

Authors:  Gaojie Li; Yuanxia Gu; Qin Zou; Wei Yan; Wei Li; Yiyi Wang; Yue Xiao; Dengmei Xia; Tongying Zhan; Xingli Zhou; Qian Wang
Journal:  Dermatol Ther (Heidelb)       Date:  2022-08-11

5.  Prevalence and Characterization of Fatigue in Patients with Skin Diseases.

Authors:  Laurent Misery; Jason Shourick; Charles Taïeb
Journal:  Acta Derm Venereol       Date:  2020-11-18       Impact factor: 3.875

6.  Serum Uric Acid Levels at Admission Could Predict the Chronic Post-stroke Fatigue.

Authors:  Wenwei Ren; Junxin Wu; Zijing Wu; Shuang Yang; Xiaofang Jiang; Minjie Xu; Beilan Wu; Caixia Xie; Jincai He; Xin Yu
Journal:  Front Nutr       Date:  2022-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.